作者
Jerzy-Roch Nofer, Markus Van Der Giet, Markus Tölle, Iza Wolinska, Karin von Wnuck Lipinski, Hideo A Baba, Uwe J Tietge, Axel Gödecke, Isao Ishii, Burkhard Kleuser, Michael Schäfers, Manfred Fobker, Walter Zidek, Gerd Assmann, Jerold Chun, Bodo Levkau
发表日期
2004/2/15
期刊
The Journal of clinical investigation
卷号
113
期号
4
页码范围
569-581
出版商
American Society for Clinical Investigation
简介
HDL is a major atheroprotective factor, but the mechanisms underlying this effect are still obscure. HDL binding to scavenger receptor-BI has been shown to activate eNOS, although the responsible HDL entities and signaling pathways have remained enigmatic. Here we show that HDL stimulates NO release in human endothelial cells and induces vasodilation in isolated aortae via intracellular Ca2+ mobilization and Akt-mediated eNOS phosphorylation. The vasoactive effects of HDL could be mimicked by three lysophospholipids present in HDL: sphingosylphosphorylcholine (SPC), sphingosine-1-phosphate (S1P), and lysosulfatide (LSF). All three elevated intracellular Ca2+ concentration and activated Akt and eNOS, which resulted in NO release and vasodilation. Deficiency of the lysophospholipid receptor S1P3 (also known as LPB3 and EDG3) abolished the vasodilatory effects of SPC, S1P, and LSF and …
引用总数
200420052006200720082009201020112012201320142015201620172018201920202021202220232024213347525343665046785145503335424031372310
学术搜索中的文章
JR Nofer, M Van Der Giet, M Tölle, I Wolinska… - The Journal of clinical investigation, 2004